Mount Sinai Nov 16, 2021 Cancer Genomic Analysis Reveals Distinct Features in Tumors From Patients Under 50 Years Old Nov 5, 2021 In Brief This Week: Daiichi Sankyo, AstraZeneca, Mary Bird Perkins Cancer Center, Guardant Health Aug 27, 2021 In Brief This Week:Â Roche, Immunocore, OrigiMed, Mount Sinai, Caris Life Sciences, CellMax Life Jul 30, 2021 Mount Sinai Seeking Pharma Partner to Advance Promising AKT Degrader Premium Jun 24, 2021 Overexpressed Cancer Testis Antigen Could Reflect Therapeutic Target in Liver Cancer Apr 9, 2021 Gene Expression Score IDs PD-1/PD-L1 Immune Checkpoint Inhibitor Resistance in Bladder Cancers Mar 17, 2021 Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy Premium Jun 22, 2020 Onconova to Enroll Patients With KRAS-Mutated Lung Cancer in Phase I/II Rigosertib Trials May 22, 2019 Fruit Fly Model Provides Personalized Cancer Therapy Recommendation May 3, 2019 Startup My Personal Therapeutics to Apply AI, Fruit Fly Models for Cancer Rx Recommendations Premium Aug 29, 2018 Bladder Cancer Response to Immunotherapy Informed by Expression Profiles Aug 13, 2018 Mt. Sinai Researchers Use Multi-Omics Approach to Personalize Relapsed Multiple Myeloma Treatment Oct 30, 2017 Gene Profiling Uncovers Actionable Mutations in More Than Half of Non-Small Cell Lung Cancers Breaking News Dragonfly Therapeutics Begins Phase II Trial of HER2-Targeted NK-Cell Engager Touchlight to Provide DNA Vector for Odimma Therapeutics' Personalized Neoantigen Vaccine Trial FDA Approves Thermo Fisher HLA Typing Test as CDx for Immunocore Uveal Melanoma Therapy Caris Life Sciences, Hummingbird Bioscience Partner on Anti-HER3 Therapy Advancement Akeso, Summit Therapeutics Ink $5B Licensing Deal for PD-1/VEGF Bispecific Antibody Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients
